Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia. 

FDA Issues Letter About Paclitaxel Coated Balloons and Eluting Stents
News | Peripheral Artery Disease (PAD) | January 17, 2019

January 17, 2019 — The U.S. Food and Drug Administration (FDA) issued a letter...

New Appropriate Use Criteria Released for Peripheral Artery Interventions
News | Peripheral Artery Disease (PAD) | December 19, 2018

December 19, 2018 — A new set of appropriate use criteria (AUC) released Dec. 17 by a group of cardiovascular...

Merit Medical Acquires Assets of Vascular Insights LLC
News | Catheters | December 18, 2018

December 18, 2018 — Merit Medical Systems Inc. announced that it has acquired substantially all of the assets of...

Shockwave Announces Collaboration With Abiomed on Physician Training
News | Cath Lab | December 14, 2018

December 14, 2018 – Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As...

Lithotripsy Safe and Effective in Calcified Stenotic Peripheral Arteries
News | Peripheral Artery Disease (PAD) | December 04, 2018

December 4, 2018 — New results from the DISRUPT PAD II study showed no perforations, embolization, reflow or abrupt...

iDissection Classification Study to Evaluate Dissection Rate of Flex Dynamic Scoring Catheter
News | Peripheral Artery Disease (PAD) | November 09, 2018

November 9, 2018 — VentureMed Group Inc. announced the initiation of a...

Lutonix 014 Drug-Coated Balloon Safe and Effective Below the Knee
News | Peripheral Artery Disease (PAD) | November 07, 2018

November 7, 2018 — The Lutonix Drug-Coated Balloon (DCB) showed statistically significant safety equivalence with a...

Veryan Medical's BioMimics 3D Stent Receives PMA Approval
Technology | Stents Peripheral | October 05, 2018

October 5, 2018 — Veryan Medical Ltd has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent...

Boston Scientific Receives FDA Approval for Eluvia Drug-Eluting Vascular Stent
Technology | Stents Drug Eluting | October 01, 2018

October 1, 2018 — Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its...

Eluvia Drug-Eluting Stent Demonstrates Superior Patency in IMPERIAL Trial
News | Stents Drug Eluting | September 26, 2018

September 26, 2018 — Positive 12-month data from the late-breaking IMPERIAL trial was presented at the 2018...

Three-Year Real-World Data Support In.Pact Admiral as Primary PAD Therapy
News | Drug-Eluting Balloons | September 24, 2018

September 24, 2018 — New data announced at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept...

AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient
News | Blood Testing | September 04, 2018

September 4, 2018 — Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses...

Lokai Medical to Distribute NuCryo Vascular PolarCath Balloon Dilatation System in U.S.
News | Peripheral Artery Disease (PAD) | August 14, 2018

August 14, 2018 — NuCryo Vascular announced that the company has signed a commercialization agreement with Lokai...

News | Venous Therapies | August 08, 2018

August 8, 2018 — Boston Scientific Corp. announced it has signed an agreement to...

Overlay Init